Inventor · disambiguated record
Mark Smith
Also filed as: SMITH MARK · SMITH MARK A · SMITH MARK ALAN · SMITH MARK F
28 granted patents·30 pending applications·399 citations·filing 1998–2024
96Inventor score
Files withTEVA PHARMACEUTICALS INT GMBH7SMITH MARK A5SYMBIONT IO INC5ASTRAZENECA AB4TEZAPSIDIS NIKOLAOS4
Top patents by PatentIndex Score
58 records- 0196US10476847B1Systems, methods, and devices for implementing a smart contract on a distributed ledger technology platformSYMBIONT IO INC·Filed 2019·Granted Nov 12, 2019·117 cites·21 claims
- 0293US11057353B2Systems, methods, and devices for implementing a smart contract on a distributed ledger technology platformSYMBIONT IO INC·Filed 2019·Granted Jul 6, 2021·17 cites·20 claims
- 0392US6579885B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofALBANY MOLECULAR RES INC·Filed 2002·Granted Jun 17, 2003·50 cites·25 claims
- 0491US10851066B22-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative diseasesUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Dec 1, 2020·2 cites·5 claims
- 0590US7163949B14-phenyl substituted tetrahydroisoquinolines and use thereofAMR TECHNOLOGY INC·Filed 2000·Granted Jan 16, 2007·26 cites·38 claims
- 0688US10825024B1Systems, devices, and methods for DLT-based data management platforms and data productsSYMBIONT IO INC·Filed 2020·Granted Nov 3, 2020·3 cites·19 claims
- 0783US10646443B2Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted May 12, 2020·2 cites·58 claims
- 0883US8716220B2Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid betaTEZAPSIDIS NIKOLAOS·Filed 2009·Granted May 6, 2014·9 cites·4 claims
- 0982US8642543B2Methods for treating progressive cognitive disorders related to neurofibrillary tanglesTEZAPSIDIS NIKOLAOS·Filed 2009·Granted Feb 4, 2014·8 cites·11 claims
- 1082US7612090B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofALBANY MOLECULAR RES INC·Filed 2003·Granted Nov 3, 2009·15 cites·8 claims
- 1181US7821422B2Traffic light signal system using radar-based target detection and trackingLIGHT VISION SYSTEMS INC·Filed 2004·Granted Oct 26, 2010·57 cites·65 claims
- 1280US7265116B2Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereofARM TECHNOLOGY INC·Filed 2004·Granted Sep 4, 2007·17 cites·30 claims
- 1378US2024238307A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 1475US10298016B1Systems, methods and computer program products for electric grid controlNAT TECH & ENG SOLUTIONS SANDIA LLC·Filed 2017·Granted May 21, 2019·4 cites·10 claims
- 1575US2025073166A1Sustained Release Olanzapine FormulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2024·Application pending·0 cites
- 1674US7590710B1Method and system for extending a communication port via a general purpose networkWAVETRIX INC·Filed 2004·Granted Sep 15, 2009·33 cites·27 claims
- 1773US7420699B2Systems and methods for rapid processing of raster intensive color documentsXEROX CORP·Filed 2003·Granted Sep 2, 2008·20 cites·11 claims
- 1872US11111217B22-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseasesUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 7, 2021·0 cites·3 claims
- 1972US2022323458A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2022·Application pending·0 cites
- 2070US8416413B2Products and methods for identifying rock samplesELLINGTON JR WILLIAM EUGENE·Filed 2011·Granted Apr 9, 2013·3 cites·4 claims
- 2169US11869012B2Systems, devices, and methods for DLT-based data management platforms and data productsSYMBIONT IO INC·Filed 2022·Granted Jan 9, 2024·0 cites·20 claims
- 2263US11813359B2Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2020·Granted Nov 14, 2023·0 cites·18 claims
- 2363US2009291966A1Method Of Treating Anxious Major Depressive DisorderASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2463US2018264001A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Application pending·0 cites
- 2562US12195432B22-arylbenzimidazoles as Ppargc1a activators for treating neurodegenerative diseasesUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jan 14, 2025·0 cites·12 claims
- 2661US11436607B2Systems, devices, and methods for DLT-based data management platforms and data productsSYMBIONT IO INC·Filed 2020·Granted Sep 6, 2022·0 cites·19 claims
- 2761US9547797B2Managing vehicular traffic on a roadwayHOVTAG LLC·Filed 2014·Granted Jan 17, 2017·1 cites·8 claims
- 2860US2010274649A1Credit card providing enhanced benefits, method and system for using sameSMITH MARK A·Filed 2009·Application pending·0 cites
- 2960US2010283203A1Itinerary fulfillment travel game and method of playSMITH MARK ALAN·Filed 2009·Application pending·0 cites
- 3058US2017079985A1Sustained release olanzapine formulationsTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Application pending·0 cites
- 3158US2010034741A1Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptorPOMPER MARTIN G·Filed 2009·Application pending·0 cites
- 3257US2010028361A1Brain-derived gonadotropins and cognitionSMITH MARK A·Filed 2007·Application pending·0 cites
- 3357US2014121157A1Methods for treating progressive cognitive disorders related to neurofibrillary tanglesTEZAPSIDIS NIKOLAOS·Filed 2013·Application pending·0 cites
- 3456US12457200B2Systems, methods, and devices for implementing a smart contract on a distributed ledger technology platformPLATONIC HOLDINGS INC·Filed 2021·Granted Oct 28, 2025·0 cites·20 claims
- 3554US2015038409A1Leptin Compositions and Methods for Treating Progressive Cognitive Function Disorders Resulting from Accumulation of Neurofibrillary Tangles and Amyloid BetaTEZAPSIDIS NIKOLAOS·Filed 2013·Application pending·0 cites
- 3653US2005273419A1Method for executing block orders of commoditiesLAVA TRADING INC·Filed 2004·Application pending·0 cites
- 3753US2005246263A1Automated system for routing orders for foreign exchange transactionsLAVA TRADING INC·Filed 2004·Application pending·0 cites
- 3851US6548261B1Alzheimer model for drug screeningUNIV CASE WESTERN RESERVE·Filed 1998·Granted Apr 15, 2003·15 cites·6 claims
- 3950US2010047233A1Treatment of post-menopausal and post-hysterectomy mediated cognitive disordersSMITH MARK A·Filed 2007·Application pending·0 cites
- 4048US7982038B2LigandsASTRAZENECA AB·Filed 2004·Granted Jul 19, 2011·0 cites·3 claims
- 4148US2015057317A1Gabr-a2 diagnosticASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 4248US2012070445A1Brain-derived gonadotropins and cognitionSMITH MARK A·Filed 2011·Application pending·0 cites
- 4347US8823937B2Products and methods for identifying rock samplesELLINGTON & ASSOCIATES INC·Filed 2013·Granted Sep 2, 2014·0 cites·23 claims
- 4447US7510871B2Alzheimer model for drug screeningUNIV CASE WESTERN RESERVE·Filed 2003·Granted Mar 31, 2009·0 cites·11 claims
- 4547US2005246195A1System and method for developing and commercializing technologySMITH MARK F·Filed 2005·Application pending·0 cites
- 4646US2013197041A1Gabr-a2 diagnosticASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 4746US2009312986A1Method and System for Determining Specified Data Related to Underground InstallationsGEOSPATIAL HOLDINGS INC·Filed 2009·Application pending·0 cites
- 4846US2005129610A1Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptorUNIV JOHNS HOPKINS·Filed 2004·Application pending·0 cites
- 4946US2023210867A1Treatment of adjustment disordersVISTAGEN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5044US2012178763A1Method of Treating Anxious Major Depressive DisorderFREY JOSEPH·Filed 2011·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →